Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors

Margot P. Cleary, Frederick C. Phillips, Susan C. Getzin, Tina L. Jacobson, Michelle K. Jacobson, Trace A. Christensen, Subhash C. Juneja, Joseph P. Grande, Nita Jane Maihle

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Elevated body weight is a risk factor for postmenopausal breast cancer and is associated with increased incidence of spontaneous and chemically induced mammary tumors (MTs) in rodents. In this study, genetically obese Lepob Lepob female mice that overexpress human TGF-α (transforming growth factor-alpha) were used to assess the role of body weight on oncogene-induced MT development in comparison to lean counterparts. MMTV (mouse mammary tumor virus)-TGF-α and Lep strain mice were crossed to produce TGF-α/Lep+ Lep+ (homozygous lean), TGF-α/Lep+ Lepob (heterozygous lean) and TGF-α/Lepob Lepob (homozygous obese) genotypes. Body weights were determined weekly and mice palpated for the presence of MTs until 104 weeks of age. Despite their significantly higher body weight, obese TGF-α/Lepob Lepob mice failed to develop MTs. MTs were detected between 48 and 104 weeks of age for 26/39 TGF-α/Lep+ Lepob mice and for 19/38 TGF-α/Lep+ Lep+ mice between 67 and 104 weeks of age. Although MT incidence was not statistically different between the lean groups, age of MT detection tended to be younger for TGF-α/Lep+ Lepob mice (p < 0.09). There were significant effects of both genotype and MTs on final body weight, that is, TGF-α/Lep+ Lepob mice weighed more than homozygous lean mice, and mice with MTs weighed more than those without MTs. TGF-α/Lepob Lepob mice are not a good model to evaluate the effect of body weight on MT development possibly due to leptin deficiency. However, the finding that increased body weight is associated with increased oncogene-induced MT development within the normal weight range provides experimental support for the role of body weight in breast cancer.

Original languageEnglish (US)
Pages (from-to)205-215
Number of pages11
JournalBreast Cancer Research and Treatment
Volume77
Issue number3
DOIs
StatePublished - Feb 1 2003

Fingerprint

Mouse mammary tumor virus
Obese Mice
Transforming Growth Factor alpha
Breast Neoplasms
Body Weight
Oncogenes
Genotype
Incidence
Leptin

Keywords

  • Body weight
  • Heterozygous
  • Leptin
  • Mammary tumors
  • Obesity
  • Ovarian tumors
  • Postmenopausal breast cancer
  • Transgenic mice

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cleary, M. P., Phillips, F. C., Getzin, S. C., Jacobson, T. L., Jacobson, M. K., Christensen, T. A., ... Maihle, N. J. (2003). Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Research and Treatment, 77(3), 205-215. https://doi.org/10.1023/A:1021891825399

Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. / Cleary, Margot P.; Phillips, Frederick C.; Getzin, Susan C.; Jacobson, Tina L.; Jacobson, Michelle K.; Christensen, Trace A.; Juneja, Subhash C.; Grande, Joseph P.; Maihle, Nita Jane.

In: Breast Cancer Research and Treatment, Vol. 77, No. 3, 01.02.2003, p. 205-215.

Research output: Contribution to journalArticle

Cleary, MP, Phillips, FC, Getzin, SC, Jacobson, TL, Jacobson, MK, Christensen, TA, Juneja, SC, Grande, JP & Maihle, NJ 2003, 'Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors', Breast Cancer Research and Treatment, vol. 77, no. 3, pp. 205-215. https://doi.org/10.1023/A:1021891825399
Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA et al. Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Research and Treatment. 2003 Feb 1;77(3):205-215. https://doi.org/10.1023/A:1021891825399
Cleary, Margot P. ; Phillips, Frederick C. ; Getzin, Susan C. ; Jacobson, Tina L. ; Jacobson, Michelle K. ; Christensen, Trace A. ; Juneja, Subhash C. ; Grande, Joseph P. ; Maihle, Nita Jane. / Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. In: Breast Cancer Research and Treatment. 2003 ; Vol. 77, No. 3. pp. 205-215.
@article{2268253d4e174fb5af35f3073452bceb,
title = "Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors",
abstract = "Elevated body weight is a risk factor for postmenopausal breast cancer and is associated with increased incidence of spontaneous and chemically induced mammary tumors (MTs) in rodents. In this study, genetically obese Lepob Lepob female mice that overexpress human TGF-α (transforming growth factor-alpha) were used to assess the role of body weight on oncogene-induced MT development in comparison to lean counterparts. MMTV (mouse mammary tumor virus)-TGF-α and Lep strain mice were crossed to produce TGF-α/Lep+ Lep+ (homozygous lean), TGF-α/Lep+ Lepob (heterozygous lean) and TGF-α/Lepob Lepob (homozygous obese) genotypes. Body weights were determined weekly and mice palpated for the presence of MTs until 104 weeks of age. Despite their significantly higher body weight, obese TGF-α/Lepob Lepob mice failed to develop MTs. MTs were detected between 48 and 104 weeks of age for 26/39 TGF-α/Lep+ Lepob mice and for 19/38 TGF-α/Lep+ Lep+ mice between 67 and 104 weeks of age. Although MT incidence was not statistically different between the lean groups, age of MT detection tended to be younger for TGF-α/Lep+ Lepob mice (p < 0.09). There were significant effects of both genotype and MTs on final body weight, that is, TGF-α/Lep+ Lepob mice weighed more than homozygous lean mice, and mice with MTs weighed more than those without MTs. TGF-α/Lepob Lepob mice are not a good model to evaluate the effect of body weight on MT development possibly due to leptin deficiency. However, the finding that increased body weight is associated with increased oncogene-induced MT development within the normal weight range provides experimental support for the role of body weight in breast cancer.",
keywords = "Body weight, Heterozygous, Leptin, Mammary tumors, Obesity, Ovarian tumors, Postmenopausal breast cancer, Transgenic mice",
author = "Cleary, {Margot P.} and Phillips, {Frederick C.} and Getzin, {Susan C.} and Jacobson, {Tina L.} and Jacobson, {Michelle K.} and Christensen, {Trace A.} and Juneja, {Subhash C.} and Grande, {Joseph P.} and Maihle, {Nita Jane}",
year = "2003",
month = "2",
day = "1",
doi = "10.1023/A:1021891825399",
language = "English (US)",
volume = "77",
pages = "205--215",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors

AU - Cleary, Margot P.

AU - Phillips, Frederick C.

AU - Getzin, Susan C.

AU - Jacobson, Tina L.

AU - Jacobson, Michelle K.

AU - Christensen, Trace A.

AU - Juneja, Subhash C.

AU - Grande, Joseph P.

AU - Maihle, Nita Jane

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Elevated body weight is a risk factor for postmenopausal breast cancer and is associated with increased incidence of spontaneous and chemically induced mammary tumors (MTs) in rodents. In this study, genetically obese Lepob Lepob female mice that overexpress human TGF-α (transforming growth factor-alpha) were used to assess the role of body weight on oncogene-induced MT development in comparison to lean counterparts. MMTV (mouse mammary tumor virus)-TGF-α and Lep strain mice were crossed to produce TGF-α/Lep+ Lep+ (homozygous lean), TGF-α/Lep+ Lepob (heterozygous lean) and TGF-α/Lepob Lepob (homozygous obese) genotypes. Body weights were determined weekly and mice palpated for the presence of MTs until 104 weeks of age. Despite their significantly higher body weight, obese TGF-α/Lepob Lepob mice failed to develop MTs. MTs were detected between 48 and 104 weeks of age for 26/39 TGF-α/Lep+ Lepob mice and for 19/38 TGF-α/Lep+ Lep+ mice between 67 and 104 weeks of age. Although MT incidence was not statistically different between the lean groups, age of MT detection tended to be younger for TGF-α/Lep+ Lepob mice (p < 0.09). There were significant effects of both genotype and MTs on final body weight, that is, TGF-α/Lep+ Lepob mice weighed more than homozygous lean mice, and mice with MTs weighed more than those without MTs. TGF-α/Lepob Lepob mice are not a good model to evaluate the effect of body weight on MT development possibly due to leptin deficiency. However, the finding that increased body weight is associated with increased oncogene-induced MT development within the normal weight range provides experimental support for the role of body weight in breast cancer.

AB - Elevated body weight is a risk factor for postmenopausal breast cancer and is associated with increased incidence of spontaneous and chemically induced mammary tumors (MTs) in rodents. In this study, genetically obese Lepob Lepob female mice that overexpress human TGF-α (transforming growth factor-alpha) were used to assess the role of body weight on oncogene-induced MT development in comparison to lean counterparts. MMTV (mouse mammary tumor virus)-TGF-α and Lep strain mice were crossed to produce TGF-α/Lep+ Lep+ (homozygous lean), TGF-α/Lep+ Lepob (heterozygous lean) and TGF-α/Lepob Lepob (homozygous obese) genotypes. Body weights were determined weekly and mice palpated for the presence of MTs until 104 weeks of age. Despite their significantly higher body weight, obese TGF-α/Lepob Lepob mice failed to develop MTs. MTs were detected between 48 and 104 weeks of age for 26/39 TGF-α/Lep+ Lepob mice and for 19/38 TGF-α/Lep+ Lep+ mice between 67 and 104 weeks of age. Although MT incidence was not statistically different between the lean groups, age of MT detection tended to be younger for TGF-α/Lep+ Lepob mice (p < 0.09). There were significant effects of both genotype and MTs on final body weight, that is, TGF-α/Lep+ Lepob mice weighed more than homozygous lean mice, and mice with MTs weighed more than those without MTs. TGF-α/Lepob Lepob mice are not a good model to evaluate the effect of body weight on MT development possibly due to leptin deficiency. However, the finding that increased body weight is associated with increased oncogene-induced MT development within the normal weight range provides experimental support for the role of body weight in breast cancer.

KW - Body weight

KW - Heterozygous

KW - Leptin

KW - Mammary tumors

KW - Obesity

KW - Ovarian tumors

KW - Postmenopausal breast cancer

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=12244313739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12244313739&partnerID=8YFLogxK

U2 - 10.1023/A:1021891825399

DO - 10.1023/A:1021891825399

M3 - Article

VL - 77

SP - 205

EP - 215

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -